This resolution expresses congressional support for designating the week of May 3-9, 2026, as "Tardive Dyskinesia Awareness Week." Tardive dyskinesia is an involuntary movement disorder that can develop in people taking certain medications used to treat mental health conditions like schizophrenia and bipolar disorder, as well as gastrointestinal disorders. The resolution notes that approximately 600,000 Americans have the condition, with about 60 percent remaining undiagnosed, and that regular screening by healthcare providers is recommended. The resolution encourages public awareness and education about tardive dyskinesia symptoms and available FDA-approved treatments. This is a symbolic measure with no direct funding or binding requirements; it simply expresses the House's support for raising awareness about this medical condition.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.